Cencora, Inc.

COR ·Healthcare, Medical Distribution, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $84.75B $78.36B $85.93B $83.73B $80.66B $75.45B $81.49B $79.05B
Cost of Revenue $81.15B $74.77B $82.86B $80.77B $77.76B $72.39B $78.93B $76.56B
Gross Profit $3.61B $3.59B $3.07B $2.95B $2.91B $3.06B $2.56B $2.49B
Gross Margin 4.3% 4.6% 3.6% 3.5% 3.6% 4.1% 3.1% 3.2%
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense $2.13B $1.98B $1.80B $1.75B $1.67B $1.60B $1.47B $1.49B
Operating Income $1.12B $1.14B $760.4M $18.5M $867.7M $1.04B $706.3M $126.6M
Operating Margin 1.3% 1.5% 0.9% 0.0% 1.1% 1.4% 0.9% 0.2%
Interest Expense — — — — — — — —
Pretax Income $996.4M $2.09B $708.6M $-187.0M $896.3M $928.7M $620.4M $125.2M
Income Tax Expense $219.7M $459.0M $142.5M $146.0M $206.5M $211.2M $126.7M $117.7M
Net Income $763.5M $1.64B $559.6M $-339.7M $687.4M $717.9M $488.6M $3.4M
Net Margin 0.9% 2.1% 0.7% -0.4% 0.9% 1.0% 0.6% 0.0%
EPS (Basic) $3.95 $8.44 $2.88 $-1.75 $3.55 $3.70 $2.52 $0.04
EPS (Diluted) $3.94 $8.40 $2.87 $-1.74 $3.52 $3.68 $2.50 $0.04
Shares Outstanding (Basic) 193.1M 194.5M 194.2M 193.8M 193.8M 193.8M 193.8M 198.5M
Shares Outstanding (Diluted) 193.9M 195.4M 195.3M 195.2M 195.2M 195.1M 195.2M 200.3M
Dividends Per Share $0.60 $0.60 $0.60 $0.55 $0.55 $0.55 $0.55 $0.51
← Newer Page 1 of 9 Older →